Annual Operating Expenses
$22.38 M
+$2.22 M+11.03%
December 31, 2022
Summary
- As of February 26, 2025, BLPH annual total operating expenses is $22.38 million, with the most recent change of +$2.22 million (+11.03%) on December 31, 2022.
- During the last 3 years, BLPH annual operating expenses has risen by +$4.91 million (+28.11%).
Performance
BLPH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$2.17 M
-$3.09 M-58.74%
September 30, 2023
Summary
- As of February 26, 2025, BLPH quarterly total operating expenses is $2.17 million, with the most recent change of -$3.09 million (-58.74%) on September 30, 2023.
- Over the past year, BLPH quarterly operating expenses has dropped by -$2.95 million (-57.58%).
Performance
BLPH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BLPH Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.0% | -57.6% |
| 3 y3 years | +28.1% | -57.6% |
| 5 y5 years | -9.0% | -68.2% |
BLPH Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -9.9% | -66.8% | at low |
| 5 y | 5-year | -14.8% | -21.9% | -73.7% | at low |
| alltime | all time | -63.9% | -21.9% | -87.2% | at low |
Bellerophon Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $2.17 M(-58.7%) |
| Jun 2023 | - | $5.26 M(+26.4%) |
| Mar 2023 | - | $4.16 M(-18.2%) |
| Dec 2022 | $22.38 M(+11.0%) | $5.08 M(-0.6%) |
| Sep 2022 | - | $5.12 M(-21.8%) |
| Jun 2022 | - | $6.54 M(+15.9%) |
| Mar 2022 | - | $5.64 M(+32.0%) |
| Dec 2021 | $20.16 M(-23.3%) | $4.27 M(-11.0%) |
| Sep 2021 | - | $4.80 M(-8.1%) |
| Jun 2021 | - | $5.23 M(-10.8%) |
| Mar 2021 | - | $5.86 M(-28.1%) |
| Dec 2020 | $26.28 M(+50.4%) | $8.15 M(-1.4%) |
| Sep 2020 | - | $8.26 M(+43.4%) |
| Jun 2020 | - | $5.76 M(+40.1%) |
| Mar 2020 | - | $4.11 M(-4.8%) |
| Dec 2019 | $17.47 M(-37.3%) | $4.32 M(-6.0%) |
| Sep 2019 | - | $4.59 M(+8.7%) |
| Jun 2019 | - | $4.22 M(-2.7%) |
| Mar 2019 | - | $4.34 M(-7.3%) |
| Dec 2018 | $27.88 M | $4.68 M(-31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $6.83 M(-13.2%) |
| Jun 2018 | - | $7.87 M(-7.3%) |
| Mar 2018 | - | $8.49 M(+16.2%) |
| Dec 2017 | $24.60 M(+3.5%) | $7.31 M(+18.2%) |
| Sep 2017 | - | $6.18 M(-2.2%) |
| Jun 2017 | - | $6.32 M(+32.2%) |
| Mar 2017 | - | $4.78 M(-34.4%) |
| Dec 2016 | $23.76 M(-50.7%) | $7.29 M(+72.9%) |
| Sep 2016 | - | $4.22 M(-18.3%) |
| Jun 2016 | - | $5.16 M(-27.2%) |
| Mar 2016 | - | $7.09 M(-34.7%) |
| Dec 2015 | $48.23 M(-19.3%) | $10.86 M(-2.7%) |
| Sep 2015 | - | $11.17 M(-3.8%) |
| Jun 2015 | - | $11.61 M(-10.2%) |
| Mar 2015 | - | $12.93 M(+1.1%) |
| Dec 2014 | $59.75 M(-3.6%) | $12.79 M(-17.5%) |
| Sep 2014 | - | $15.49 M(-8.7%) |
| Jun 2014 | - | $16.96 M(+16.9%) |
| Mar 2014 | - | $14.51 M(-13.5%) |
| Dec 2013 | $62.00 M(+34.1%) | $16.77 M |
| Dec 2012 | $46.23 M | - |
FAQ
- What is Bellerophon Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual operating expenses year-on-year change?
- What is Bellerophon Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly operating expenses year-on-year change?
What is Bellerophon Therapeutics annual total operating expenses?
The current annual operating expenses of BLPH is $22.38 M
What is the all time high annual operating expenses for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual total operating expenses is $62.00 M
What is Bellerophon Therapeutics annual operating expenses year-on-year change?
Over the past year, BLPH annual total operating expenses has changed by +$2.22 M (+11.03%)
What is Bellerophon Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BLPH is $2.17 M
What is the all time high quarterly operating expenses for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly total operating expenses is $16.96 M
What is Bellerophon Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BLPH quarterly total operating expenses has changed by -$2.95 M (-57.58%)